Raia Drogasil S/A

Country
Brazil
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
67,114
Ticker
RADL3
Exchange
B3 S.A.
Description
Raia Drogasil S.A. is a prominent player within the Brazilian pharmaceutical and retail health industry. Known for operating a vast network of drugstores throughout Brazil, Raia Drogasil's primary fun...

Financial Statements of Raia Drogasil S/A

Below are the financial statements of Raia Drogasil S/A, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of BRL20242023
Net sales revenue
38,871.52a
33,973.79a
Cost of sales and services
-27,314.74a
-23,766.43a
Gross profit
11,556.78a
10,207.36a
Operating (expenses) income
Selling
-7,627.82a
-6,689.28a
General and administrative
-1,570.63a
-1,503.53a
Other operating income/(expenses)
-7.3a
78.44a
Equity in the results of subsidiaries
1.07a
-12.51a
Operating profit before finance results
2,352.11a
2,080.49a
Finance income (costs)
Finance income
444.59a
428.74a
Finance costs
-1,377.7a
-1,292.53a
Profit before income tax and social contribution
1,418.99a
1,216.69a
Income tax and social contribution
Current
-328.23a
-314.52a
Deferred
-120.61a
-184.97a
Profit for the year
1,211.37a
1,087.14a
Attributable to
Owners of the company
1,199.86a
1,054.97a
Noncontrolling interests
11.51a
32.17a
Download Data

Verified Sources Behind Raia Drogasil S/A’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Raia Drogasil S/A’s data sources below and access millions more through our Disclosure Search.

a. Raia Drogasil S/A's Financial Report 2024
a. Raia Drogasil S/A's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?